Copertina

Host genetic variants in the lactose metabolism pathway associated with bifidobacterium abundance have prognostic value for immunotherapy efficacy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Wen‐Hui Liu, Chen‐Lin Xiao, Zhi‐Ying Luo, Ya‐Jun Zhu, Wen‐Ru Li, Huan Ren, Zhen Guo, Jian‐Quan Luo
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Imperatorin ameliorates metabolic dysfunction‐associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway
di: Yi Sun, et al.
Pubblicazione: (2025)

Covalent fluorescent probes for 2‐arachidonoylglycerol metabolic pathways
di: Nick D. F. Puijmbroeck, et al.
Pubblicazione: (2026)

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy
di: Zihan Qu, et al.
Pubblicazione: (2024)

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
di: Rao Hu, et al.
Pubblicazione: (2026)

Metformin aggravates pancreatitis by regulating the release of oxidised mitochondrial DNA via the frataxin (FXN)/ninjurin 1 (NINJ1) signalling pathway
di: Guang Xin, et al.
Pubblicazione: (2025)

Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent
di: Bing Shang, et al.
Pubblicazione: (2024)

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis
di: Ashleigh Hooimeyer, et al.
Pubblicazione: (2026)

Pharmacogenetic CYP2B6 variants affect steroid hormone metabolism in human breast cancer cells
di: Marco Hoffmann, et al.
Pubblicazione: (2026)

Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis
di: Danli Cao, et al.
Pubblicazione: (2025)

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
di: Qingxiang Lin, et al.
Pubblicazione: (2024)

TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4‐CREB pathway
di: Shan Jiang, et al.
Pubblicazione: (2025)

Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation
di: Chun‐Yu Lo, et al.
Pubblicazione: (2025)

The neuronal ALAS2/5‐ala axis mitigates chemotherapy‐induced neurotoxicity via the BACH1/NRF2 pathway
di: Wen‐yuan Zhang, et al.
Pubblicazione: (2026)

Imatinib aggravates pressure‐overload‐induced right ventricle failure via JNK/Runx2 pathway
di: Xiaohui Zeng, et al.
Pubblicazione: (2025)

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis
di: Andrej Belančić, et al.
Pubblicazione: (2026)

Reprogramming tumour‐associated macrophages in breast cancer via si‐FOXM1‐loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy
di: Yali Gao, et al.
Pubblicazione: (2026)

Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer
di: Timothée David, et al.
Pubblicazione: (2024)

Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway
di: Yi‐Wen Nie, et al.
Pubblicazione: (2025)

The NOS1AP gene rs10494366 common genetic variant does not modify the risk of sudden cardiac death in users of digoxin
di: Negin Soroush, et al.
Pubblicazione: (2024)

In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants
di: Charlotte Kölz, et al.
Pubblicazione: (2024)

Inhibition of the calcineurin/forkhead box O1/fatty acid binding protein 4 pathway prevents SERCA2 dysfunction‐induced foam cell formation and atherosclerosis
di: Beibei Zhu, et al.
Pubblicazione: (2025)

Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin
di: Huan Li, et al.
Pubblicazione: (2025)

Targeted peptide‐modified M2 exosomes drug delivery system for the targeted regulation of the lung injury microenvironment with isorhynchophylline (IRN): based on the inflammatory–metabolic–epigenetic synergy mechanism
di: Jin‐Ru Zou, et al.
Pubblicazione: (2026)

2‐Hydroxyl hispolon reverses high glucose‐induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO‐1 pathways
di: Ta‐Jung Wang, et al.
Pubblicazione: (2025)

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants
di: Rosa Luo, et al.
Pubblicazione: (2025)

Hand–foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor‐tyrosine kinase inhibitor treatment
di: I‐Hsin Huang, et al.
Pubblicazione: (2026)

Interindividual variability in olanzapine steady‐state concentrations in Chinese: exploring single nucleotide polymorphisms of metabolic enzymes
di: Zhou Wan, et al.
Pubblicazione: (2025)

Ventral pallidum GABAergic and glutamatergic neurons modulate arousal during sevoflurane general anaesthesia in male mice
di: Bing‐Qian Fan, et al.
Pubblicazione: (2025)

A long‐acting FGF21 attenuates metabolic dysfunction‐associated steatohepatitis‐related fibrosis by modulating NR4A1‐mediated Ly6C phenotypic switch in macrophages
di: Yue Ji, et al.
Pubblicazione: (2024)

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
di: Feng Zhang, et al.
Pubblicazione: (2024)

SGLT2 inhibitors and their influence on iron metabolism in the context of inflammation
di: Helene G. Meyer, et al.
Pubblicazione: (2025)

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
di: Andrea Baragetti, et al.
Pubblicazione: (2026)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
di: Luca Botticelli, et al.
Pubblicazione: (2025)

Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subjects
di: Zi‐yi Zhou, et al.
Pubblicazione: (2026)

Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis
di: Yun Wang, et al.
Pubblicazione: (2024)

Preliminary efficacy and safety profile of dual histamine blockade on preventing filgrastim‐associated bone pain in breast cancer patients: Randomized controlled trial
di: Mona M. Eltamalawy, et al.
Pubblicazione: (2025)

Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
di: Yen‐Wen Wu, et al.
Pubblicazione: (2025)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
di: Geoffrey Canet, et al.
Pubblicazione: (2025)

Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling
di: Mingdian Tan, et al.
Pubblicazione: (2025)

Adverse reactions associated with nivolumab and small molecule antiangiogenic drugs: A pharmacovigilance analysis
di: Haiyang Li, et al.
Pubblicazione: (2024)